Expertise: Consulting 225 results

Consulting

When to Slow Down or Hit the Brakes on a Development Program

New drug development is a long and expensive process that can be fraught with obstacles, including unexpected delays, poor efficacy results, safety issues, or regulatory challenges. Pharmaceutical companies may, at times, find themselves at an impasse during development, facing weighty...

Consulting

A Roadmap to CMC Planning in Inhaled Combination Product Development

Creating inhaled combination products (ICPs) demands precision at the intersection of drug formulation and device engineering. These products deliver multiple active pharmaceutical ingredients (APIs) via a single device, making Chemistry, Manufacturing, and Controls (CMC) critical to ensuring safety, efficacy, and...

Consulting

The CMC Perspective on Inhaled Combination Product Development

Inhaled combination products (ICP) have emerged as a significant advancement in the treatment of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and other pulmonary conditions. Inhalation offers a targeted route of drug delivery directly to the lungs,...